236 related articles for article (PubMed ID: 36629912)
1. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice.
Lee SM; Muratalla J; Karimi S; Diaz-Ruiz A; Frutos MD; Guzman G; Ramos-Molina B; Cordoba-Chacon J
Cell Mol Life Sci; 2023 Jan; 80(2):39. PubMed ID: 36629912
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver.
Lee SM; Pusec CM; Norris GH; De Jesus A; Diaz-Ruiz A; Muratalla J; Sarmento-Cabral A; Guzman G; Layden BT; Cordoba-Chacon J
Cell Mol Gastroenterol Hepatol; 2021; 11(5):1291-1311. PubMed ID: 33444819
[TBL] [Abstract][Full Text] [Related]
3. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis, steatohepatitis, and fibrosis in male mice.
Upadhyay KK; Choi EK; Foisner R; Omary MB; Brady GF
Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G184-G195. PubMed ID: 37366543
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone Requires Hepatocyte PPARγ Expression to Promote Steatosis in Male Mice With Diet-Induced Obesity.
Lee SM; Muratalla J; Diaz-Ruiz A; Remon-Ruiz P; McCann M; Liew CW; Kineman RD; Cordoba-Chacon J
Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34417811
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.
Ni XX; Ji PX; Chen YX; Li XY; Sheng L; Lian M; Guo CJ; Hua J
Liver Int; 2022 Dec; 42(12):2696-2712. PubMed ID: 36165186
[TBL] [Abstract][Full Text] [Related]
7. Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice.
Zhao Z; Deng ZT; Huang S; Ning M; Feng Y; Shen Y; Zhao QS; Leng Y
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745142
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.
Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y
Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression.
Li L; Fu J; Liu D; Sun J; Hou Y; Chen C; Shao J; Wang L; Wang X; Zhao R; Wang H; Andersen ME; Zhang Q; Xu Y; Pi J
Redox Biol; 2020 Feb; 30():101412. PubMed ID: 31901728
[TBL] [Abstract][Full Text] [Related]
11. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
Zhong X; Liu H
J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
[TBL] [Abstract][Full Text] [Related]
12. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
[TBL] [Abstract][Full Text] [Related]
13. Inflammation is independent of steatosis in a murine model of steatohepatitis.
Wang W; Xu MJ; Cai Y; Zhou Z; Cao H; Mukhopadhyay P; Pacher P; Zheng S; Gonzalez FJ; Gao B
Hepatology; 2017 Jul; 66(1):108-123. PubMed ID: 28220523
[TBL] [Abstract][Full Text] [Related]
14. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease.
Hajri T; Zaiou M; Fungwe TV; Ouguerram K; Besong S
Cells; 2021 May; 10(6):. PubMed ID: 34072832
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
[TBL] [Abstract][Full Text] [Related]
17. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway.
Ahn JS; Yang JW; Oh SJ; Shin YY; Kang MJ; Park HR; Seo Y; Kim HS
BMB Rep; 2021 Jun; 54(6):323-328. PubMed ID: 34078528
[TBL] [Abstract][Full Text] [Related]
18. Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1/2-PPARγ-Cd36 pathway.
Li L; Sun H; Chen J; Ding C; Yang X; Han H; Sun Q
Cell Rep; 2023 Jul; 42(7):112697. PubMed ID: 37355990
[TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis.
Nielsen MH; Gillum MP; Vrang N; Jelsing J; Hansen HH; Feigh M; Oró D
Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G378-G388. PubMed ID: 36852934
[TBL] [Abstract][Full Text] [Related]
20. INT-767 improves histopathological features in a diet-induced
Roth JD; Feigh M; Veidal SS; Fensholdt LK; Rigbolt KT; Hansen HH; Chen LC; Petitjean M; Friley W; Vrang N; Jelsing J; Young M
World J Gastroenterol; 2018 Jan; 24(2):195-210. PubMed ID: 29375205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
